Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · IEX Real-Time Price · USD
1.040
+0.010 (0.97%)
At close: May 17, 2024, 4:00 PM
1.010
-0.030 (-2.88%)
After-hours: May 17, 2024, 7:49 PM EDT
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $39.49 million as of May 17, 2024. Its market cap has increased by 76.28% in one year.
Market Cap
39.49M
Enterprise Value
-8.73M
1-Year Change
76.28%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has decreased from $66.49M to $39.49M, a decrease of -40.61%. That is a compound annual growth rate of -16.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 39.10M | 1.03% |
| May 16, 2024 | 38.70M | -4.68% |
| May 15, 2024 | 40.60M | -0.98% |
| May 14, 2024 | 41.00M | - |
| May 13, 2024 | 41.00M | 4.33% |
| May 10, 2024 | 39.30M | 4.80% |
| May 9, 2024 | 37.50M | -4.58% |
| May 8, 2024 | 39.30M | -2.48% |
| May 7, 2024 | 40.30M | -1.71% |
| May 6, 2024 | 41.00M | 5.40% |
| May 3, 2024 | 38.90M | - |
| May 2, 2024 | 38.90M | -1.27% |
| May 1, 2024 | 39.40M | 1.29% |
| Apr 30, 2024 | 38.90M | -8.25% |
| Apr 29, 2024 | 42.40M | 18.44% |
| Apr 26, 2024 | 35.80M | 6.23% |
| Apr 25, 2024 | 33.70M | -6.65% |
| Apr 24, 2024 | 36.10M | -2.96% |
| Apr 23, 2024 | 37.20M | -7.00% |
| Apr 22, 2024 | 40.00M | 7.53% |
| Apr 19, 2024 | 37.20M | -1.85% |
| Apr 18, 2024 | 37.90M | -5.49% |
| Apr 17, 2024 | 40.10M | 3.08% |
| Apr 16, 2024 | 38.90M | -1.77% |
| Apr 15, 2024 | 39.60M | -6.60% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precision Optics Corporation | 39.99M |
| Inspira Technologies Oxy B.H.N. | 39.95M |
| IGC Pharma | 39.81M |
| VYNE Therapeutics | 39.66M |
| Cyclo Therapeutics | 39.34M |
| Estrella Immunopharma | 38.44M |
| NRx Pharmaceuticals | 37.77M |
| Achilles Therapeutics | 37.60M |